|1.||Diamandis, Eleftherios P: 34 articles (09/2014 - 05/2002)|
|2.||Chao, Julie: 30 articles (09/2014 - 03/2002)|
|3.||Chao, Lee: 29 articles (09/2014 - 03/2002)|
|4.||Lilja, Hans: 18 articles (01/2015 - 08/2002)|
|5.||Diamandis, E P: 13 articles (08/2011 - 01/2000)|
|6.||Scorilas, Andreas: 12 articles (09/2014 - 05/2002)|
|7.||Shen, Bo: 11 articles (01/2013 - 05/2006)|
|8.||Yousef, George M: 10 articles (04/2015 - 05/2002)|
|9.||Yin, Hang: 10 articles (01/2013 - 03/2005)|
|10.||Bledsoe, Grant: 9 articles (09/2014 - 08/2004)|
|1.||Hypertension (High Blood Pressure)
03/01/2013 - "Tissue kallikrein has been suggested to be involved in blood pressure regulation and in protection against hypertension. "
07/01/2008 - "Our study indicates that rAAV-mediated human tissue kallikrein gene delivery is a potentially safe method for the long-term treatment of hypertension. "
09/01/2007 - "The aim of this study was to investigate the association between common variants in the human tissue kallikrein 1 (KLK1) gene and susceptibility to essential hypertension in Chinese Han. "
09/01/2007 - "A coding polymorphism of the kallikrein 1 gene is associated with essential hypertension: a tagging SNP-based association study in a Chinese Han population."
09/01/2005 - "This present study aimed to study the polymorphisms of the regulatory region of human tissue kallikrein gene of the Chinese and investigate the relationship of the polymorphisms with essential hypertension. "
|2.||Prostatic Neoplasms (Prostate Cancer)
09/01/2003 - "Clinical measurement of human glandular kallikrein 2 (hK2) serves as a complementary marker to PSA for early detection of prostate cancer and constitutes a considerable improvement over PSA as a staging marker for clinically localized prostate cancer. "
04/01/2003 - "Measurement of human kallikrein 2 (hK2) has improved early detection and staging of prostate cancer. "
09/01/2005 - "In this study, we now show that the comparative expression of hK4 protein in prostate cancer tissues, compared with benign glands, is greater than that of PSA and kallikrein 2 (KLK2/hK2), suggesting that hK4 may play an important functional role in prostate cancer progression in addition to its biomarker potential. "
02/15/2003 - "In recent studies serum levels of human glandular kallikrein 2 (hK2) demonstrated significant differences in pathologically organ-confined versus non-organ-confined prostate cancer (PCa). "
02/01/2003 - "We analyzed and systematized data from studies regarding the effectiveness of PSA and human glandular kallikrein 2 and their derivatives in the detection of prostate cancer. "
10/01/2008 - "One day after myocardial infarction, tissue kallikrein treatment significantly improved cardiac contractility and reduced myocardial infarct size and left ventricle end diastolic pressure in Brown Norway Katholiek rats. "
01/01/2013 - "Tissue kallikrein-modified mesenchymal stem cells provide enhanced protection against ischemic cardiac injury after myocardial infarction."
08/01/2012 - "Tissue kallikrein (TK) has been demonstrated to improve neovasculogenesis after myocardial infarction (MI). "
04/01/2008 - "Tissue kallikrein deficiency aggravates cardiac remodelling and decreases survival after myocardial infarction in mice."
02/01/2008 - "New perspective on the tissue kallikrein-kinin system in myocardial infarction: role of angiogenesis and cardiac regeneration."
08/01/1994 - "Inhibitors of tissue kallikrein may prove effective in the treatment of allergic inflammation in man."
04/01/2005 - "The further observation of an increased tissue kallikrein activity at the systemic and saliva levels may be interpreted as a systemic reflex of skin inflammation. "
07/01/2000 - "The pharmacological activity of phenylacetyl-Phe-Ser-Arg-N-(2, 4-dinitrophenyl)-ethylenediamine (TKI), a tissue kallikrein specific inhibitor, was assessed using models of nociception and inflammation in mice. "
08/01/1994 - "Synthetic inhibitors of tissue kallikrein: effects in vivo in a model of allergic inflammation."
01/01/1989 - "Specimens of the gastric mucosa were obtained by biopsy to measure tissue kallikrein as a marker of inflammation. "
04/01/2004 - "Prophylactic gene therapy with human tissue kallikrein ameliorates limb ischemia recovery in type 1 diabetic mice."
03/04/2005 - "Our previous study has shown that human tissue kallikrein protected against ischemia/reperfusion-induced myocardial injury. "
04/01/2004 - "The present study investigated whether prophylactic gene therapy with human tissue kallikrein (hTK) may protect diabetic limbs from the consequences of supervening ischemia. "
05/01/2009 - "Here, we demonstrate that tissue kallikrein knockout mice (KLK1-/-) show impaired muscle neovascularization in response to hindlimb ischemia. "
06/01/2008 - "Tissue kallikrein and kinin infusion promotes neovascularization in limb ischemia."
|5.||Prostate-Specific Antigen (Semenogelase)
|8.||Biological Markers (Surrogate Marker)
|9.||Messenger RNA (mRNA)
|2.||Prostatectomy (Retropubic Prostatectomy)
|5.||Surgical Instruments (Clip)